A Successfully Treated Case of Recurrent Focal Segmental Glomerulosclerosis (FSGS) with Plasmapheresis and High dose Methylprednisolone Pulse Therapy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Focal segmental glomerulosclerosis (FSGS) in children, which is a kind of nephrotic syndrome showing steroid resistance, usually progresses to a substantial number of end stage renal disease (ESRD). Although the pathogenesis of primary FSGS is unclear, several recent studies have reported that FSGS is associated with circulating immune factors such as soluble urokinase-type plasminogen activator receptor (suPAR) or anti-CD40 autoantibody. We report a successfully treated case of a 19-year-old female patient who experienced a recurrence of primary FSGS. After the diagnosis of FSGS, the patient progressed to ESRD and received a kidney transplantation (KT). Three days later, recurrence was suspected through proteinuria and hypoalbuminemia. She has been performed plasmapheresis and high dose methylprednisolone pulse therapy and shown remission status without increasing proteinuria for four years after KT. In conclusion, strong immunosuppressive therapy may be helpful for a good prognosis of recurrent FSGS, suppressing several immunologic circulating factors related disease pathogenesis.
Abstract
Focal segmental glomerulosclerosis (FSGS) in children, which is a kind of nephrotic syndrome showing steroid resistance, usually progresses to a substantial number of end stage renal disease (ESRD). Although the pathogenesis of primary FSGS is unclear, several recent studies have reported that FSGS is associated with circulating immune factors such as soluble urokinase-type plasminogen activator receptor (suPAR) or anti-CD40 autoantibody. We report a successfully treated case of a 19-year-old female patient who experienced a recurrence of primary FSGS. After the diagnosis of FSGS, the patient progressed to ESRD and received a kidney transplantation (KT). Three days later, recurrence was suspected through proteinuria and hypoalbuminemia. She has been performed plasmapheresis and high dose methylprednisolone pulse therapy and shown remission status without increasing proteinuria for four years after KT. In conclusion, strong immunosuppressive therapy may be helpful for a good prognosis of recurrent FSGS, suppressing several immunologic circulating factors related disease pathogenesis.
참고문헌 (19)
- Harambat J, "Epidemiology of chronic kidney disease in children", Pediatr Nephrol, 27, pp.363~373 (2012)
- D'Agati VD, "Focal segmental glomerulosclerosis", N Engl J Med, 365, pp.2398~2411 (2011)
- Niaudet P., "Lipoid nephrosis in childhood", Rev Prat, 53, pp.2027~2032 (2003)
- Cochat P, "Disease recurrence in paediatric renal transplantation", Pediatr Nephrol, 24, pp.2097~2108 (2009)
- Zimmerman SW, "Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation", Clin Nephrol, 22, pp.32~38 (1984)
- Hayek SS, "Soluble Urokinase Receptor and Chronic Kidney Disease", N Engl J Med, 373, pp.1916~1925 (2015)
- McCarthy ET, "Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis", Clin J Am Soc Nephrol, 5, pp.2115~2121 (2010)
- Delville M, "A circulating antibody panel for pretransplant prediction of FSGS recurrence af ter kidney transplantation", Sci Transl Med, 6, pp.256ra136~ (2014)
- Cochat P, "Management of recurrent nephrotic syndrome after kidney transplantation in children", Clin Nephrol, 46, pp.17~20 (1996)
- Ehrich JH, "Combined report on regular dialysis and transplantation of children in Europe, 1989", Nephrol Dial Transplant, 6, pp.37~47 (1991)
- Baum MA, "Outcomes after renal transplantation for FSGS in children", Pediatr Transplant, 8, pp.329~333 (2004)
- Reiser J, "Permeability factors in focal and segmental glomerulosclerosis", Adv Chronic Kidney Dis, 21, pp.417~421 (2014)
- Thuno M, "suPAR: the molecular crystal ball", Dis Markers, 27, pp.157~172 (2009)
- Wei C, "Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis", Nat Med, 17, pp.952~960 (2011)
- Sever S, "Is there clinical value in measuring suPAR levels in FSGS?", Clin J Am Soc Nephrol, 8, pp.1273~1275 (2013)
- Harita Y, "Decreased glomerular filtration as the primary factor of elevated circulating suPAR levels in focal segmental glomerulosclerosis", Pediatr Nephrol, 29, pp.1553~1560 (2014)
- Fornoni A, "Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis", Sci Transl Med, 3, pp.85ra46~ (2011)
- Assmann KJ, "Antibody-induced albuminuria and accelerated focal glomerulosclerosis in the Thy-1.1 transgenic mouse", Kidney Int, 62, pp.116~126 (2002)
- Hristea D, "Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab", Transpl Int, 20, pp.102~105 (2007)